As we present the summary of the report on the main results of our company's activities for Jan. 2022 – the first half of March 2023, we cannot overlook the fact that the year was marked by a significant challenge for our team.

russia's ongoing war against Ukraine had particularly significant consequences for the residents of Kharkiv with the beginning of a full-scale invasion of russian troops on the territory of our state. From February 24, 2022, for 7 months, Kharkiv was subjected to constant massive attacks by russian troops, which caused significant damage to its infrastructure and vital activities. One of the most affected areas of the city is the Zhukovsky district, where our company is located. Many houses and buildings were destroyed or damaged; for a long time, there was no transport connection to and no working pharmacy in the area, the food supply chain was disrupted, and a large part of the district was without electricity, water and heating, which affected life and the work of our employees.

Even after the liberation of the Kharkiv region in September 2022, the city continues to be subjected to rocket strikes and other attacks from the terrorist country (russia), which does not abandon the attempts to occupy the city and the region. Many members of our team were forced to resign and look for a new place of work. Many had to move to safer cities in Ukraine or other countries. Some employees joined the ranks of the Armed Forces of Ukraine or territorial defense and defend our country from the enemy. The ongoing war prevents many residents from returning to their homes and/or normal lives.

Despite the difficult circumstances and difficulties, we are proud to report that our team has risen to the occasion and achieved notable successes. Thanks to the remarkable resilience, dedication and tireless efforts of our employees, we managed to successfully resume work in all main directions. In 2022, Supplement 6 to the State Pharmacopoeia of Ukraine (SPhU 2.6) was prepared, which was approved and put into effect on March 1, 2023 by the order of the Ministry of Health of Ukraine dated February 17, 2023. We continued to provide pharmaceutical enterprises with SPhU reference standards to ensure proper quality control of medicinal products on the Ukrainian market. Work was carried out on the development and validation of biological methods for the analysis of pharmaceutical preparations and pharmaceutical substances, as well as work on pharmacopoeial quality control of medicinal products. The 18th round of the Program for Proficiency Testing of Laboratories for the Quality Control of Medicines was prepared in 2022 and launched in January 2023. The company's specialists are experts of the WHO, the US Pharmacopoeia, the European Pharmacopoeia and Eurachem; they carried out work in the respective working groups. On March 6, 2023, the Co-operation Agreement was signed between the Ukrainian Scientific Pharmacopoeial Center for Quality of medicines and the Medicines and Healthcare Products Regulatory Agency of the United Kingdom (MHRA), according to which, in particular, it is allowed to use the texts of the British Pharmacopoeia in the State Pharmacopoeia of Ukraine. Company specialists participated in numerous international scientific and educational seminars, trainings, conferences and meetings.

One of the most significant accomplishments was that in 2022 we were able to generate income comparable to that of 2021. During the reporting period, we ensured timely payment of salaries to employees and payment of taxes to the state.

We faced significant challenges but were able to overcome them and ensure that our company remains a viable and competitive entity in the marketplace.

We are deeply grateful to all of our team members who have remained committed to our company's mission despite the challenges they have faced. We remain mindful of the ongoing war and its impact on our team and are committed to providing a safe and supportive work environment for all of our employees, regardless of where they are located. We are confident that by working together and supporting each other, we can continue to achieve success in the years to come.